CN110408639A - Pre-dyed albumen marker and preparation method thereof, application can be exposed - Google Patents
Pre-dyed albumen marker and preparation method thereof, application can be exposed Download PDFInfo
- Publication number
- CN110408639A CN110408639A CN201910709005.4A CN201910709005A CN110408639A CN 110408639 A CN110408639 A CN 110408639A CN 201910709005 A CN201910709005 A CN 201910709005A CN 110408639 A CN110408639 A CN 110408639A
- Authority
- CN
- China
- Prior art keywords
- preparation
- dyed
- molecular weight
- marker
- dyed albumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003550 marker Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 102000006830 Luminescent Proteins Human genes 0.000 claims abstract description 40
- 108010047357 Luminescent Proteins Proteins 0.000 claims abstract description 40
- 239000000975 dye Substances 0.000 claims abstract description 25
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 239000013604 expression vector Substances 0.000 claims abstract description 16
- 239000012634 fragment Substances 0.000 claims abstract description 7
- 238000012408 PCR amplification Methods 0.000 claims abstract description 5
- 230000002068 genetic effect Effects 0.000 claims abstract description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 239000000872 buffer Substances 0.000 claims description 12
- 150000007523 nucleic acids Chemical group 0.000 claims description 11
- 239000012474 protein marker Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 238000001262 western blot Methods 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 5
- 238000002474 experimental method Methods 0.000 claims description 5
- 241000588724 Escherichia coli Species 0.000 claims description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 238000013461 design Methods 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- 230000001745 anti-biotin effect Effects 0.000 description 3
- 238000009739 binding Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 102000047918 Myelin Basic Human genes 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101001123334 Homo sapiens Proteoglycan 3 Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001062009 Indigofera Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 101710110798 Mannose-binding protein C Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910001453 nickel ion Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses one kind can expose pre-dyed albumen marker and preparation method thereof, application, includes the following steps: S1, designs corresponding genetic fragment according to each protein band molecular size range, and determines corresponding expression vector;S2, the preparation expression vector, and the genetic fragment is obtained by PCR amplification;Genetic fragment is connected on corresponding expression vector, and is transferred in host cell and expressed, purified;S3, the luminescent protein of different molecular weight size is mixed with dyestuff respectively, to obtain the pre-dyed albumen of different molecular weight;S4, the pre-dyed albumen of different molecular weight size is mixed by preset ratio, obtains that pre-dyed albumen marker can be exposed.Preparation method is simple, easy to operate, and the pre-dyed albumen marker that exposes prepared is visible pre-dyed albumen, and is the luminescent protein that can be shone, and be apparent on X film.
Description
Technical field
The present invention relates to molecular biology and genetic engineering field, can expose pre-dyed albumen marker more particularly, to one kind
And preparation method thereof, application.
Background technique
Protein Marker, often referred to as albumen Marker, the standard quilt as a kind of protein molecular weight size
It is widely used in protein electrophorese.In immunoblotting (Western-blot) experiment, only Marker is accurate, experiment
As a result just convincing.In addition to this, whether successfully etc. whether albumen Marker can also prompt electrophoresis normal, transfer information.
So selecting correct albumen Marker is one of the necessary condition of western-blot Success in Experiment.
Existing albumen Marker research and development experienced common Marker, pre-dyed Marker and exposure tri- development ranks of Marker
Section.Wherein, general proteins Marker is exactly due to not being attached to dye molecule either mark molecule, shown molecular size range
The size of albumen script can accurately judge albumen size in early stage.But because can't see common Marker completely in electrophoresis process,
Finally dyeing together with target protein can just see, can not play indication reference to experimentation.
Pre-dyed Marker is by each albumen (or polypeptide) in general proteins marker by chemical modification, with a kind of indigo plant
Color or the dyestuff covalent coupling of other colors form.The appearance of pre-dyed albumen marker is brought greatly just to Western Blot
Benefit, researcher can determine purpose band according to the size of film blue (or other colors) albumen marker after transferring film
Position Approximate, to carry out the processing such as shearing to film.But pre-dyed albumen Marker can not expose on film, exposure signal
It needs to be judged according to the pre-dyed albumen Marker on film, in addition pre-dyed albumen Marker is after chemical modification in SDS-PAGE
Mobility changes in electrophoresis process, causes molecular weight information no longer accurate, so that the judgement of Western Blot result occurs
Relatively large deviation, so unsuitable accurate positioning albumen.
Exposure Marker can specifically bind primary antibody or secondary antibody, so that the final meeting of Marker band and detection target egg
It is white to appear in together in the picture of colour developing, avoid deviation occur when photo and film are compared.Such as application No. is
The preparation method of pre-dyed luminescent protein marker a kind of is disclosed in 201710707539.4 application for a patent for invention, pass through by
The luminescent protein marker and pre-dyed albumen marker mixed up obtains pre-dyed luminescent protein marker in different ratio mixing, but
The ratio of luminescent protein marker and pre-dyed albumen marker are indefinite in this kind of method, need to adjust according to the actual situation, so that system
Standby process becomes cumbersome.
Summary of the invention
In view of the foregoing drawbacks, the present invention provides one kind can expose pre-dyed albumen marker and preparation method thereof, application,
Preparation method is simple, easy to operate, and the pre-dyed albumen marker that exposes prepared is visible pre-dyed albumen, and being can
With luminous luminescent protein, and it is apparent on X film.
The technical solution that the present invention is proposed with regard to above-mentioned technical problem is as follows:
On the one hand, a kind of preparation method that can expose pre-dyed albumen marker is provided comprising following steps:
S1, corresponding nucleic acid fragment is designed according to protein band molecular size range each in pre-dyed luminescent protein marker, and
Determine corresponding expression vector;
S2, the preparation expression vector, and the genetic fragment is obtained by PCR amplification;By nucleic acid fragment be connected to
Corresponding expression vector on, and be transferred in host cell and expressed, purified, to obtain different molecular weight corresponding with band
The luminescent protein of size;
S3, the luminescent protein of different molecular weight size is mixed with dyestuff respectively, to obtain the pre-dyed egg of different molecular weight
It is white;
S4, the pre-dyed albumen of different molecular weight size is mixed by preset ratio, obtains that pre-dyed albumen marker can be exposed.
Preferably, in the step S1, the amino acid sequence of the protein band includes SEQ ID NO.1~SEQ ID
One or several in NO.6.
Preferably, in the step S1, the expression vector includes pET21a and/or pET28a-his-MBP.
Preferably, the nucleic acid sequence of the pET28a-his-MBP carrier includes sequence shown in SEQ ID NO.7.
Preferably, the host cell includes E.coli.
Preferably, the step S3 includes:
S31, the luminescent protein correspondence of different molecular weight size is placed in carbonate buffer solution, and the carbonate buffer
Liquid concentration be 0.1M, pH 9.5-10.5, with obtain it is several include corresponding molecular size range luminescent protein carbonate buffer
Liquid system;
S32, dyestuff is dissolved in the SDS solution of mass fraction 10%, it is molten for the dyestuff of 1-2% to obtain mass fraction
Liquid;
S33, by it is each include corresponding molecular size range luminescent protein carbonate buffer liquid system it is molten with dyestuff respectively
Liquid is mixed, and 25-35min is incubated under the conditions of 55-65 DEG C;And count by volume, each carbonate buffer liquid system: dyestuff is molten
Liquid=1:(0.5-1.5);
S34, the addition lysine equal with luminescent protein gross mass act on 10min under the conditions of 55-65 DEG C, remove more
Remaining dyestuff adjusts luminescent protein concentration to about 0.15-0.25mg/ml, to obtain the pre-dyed albumen of different molecular weight.
Preferably, the dyestuff includes Remazol.
Preferably, the molecular weight for exposing pre-dyed albumen marker is 35-200kDa.
On the other hand, it additionally provides and a kind of exposes pre-dyed albumen marker according to what above-mentioned preparation method prepared.
On the other hand, it additionally provides and a kind of above-mentioned exposes pre-dyed albumen marker answering in Western-Blot experiment
With.
Preparation method of the invention is simple, easy to operate, and it is not necessary that luminescent protein is prepared separately, what is prepared exposes pre-dyed
Albumen marker is without being added additional antibody, such as anti-biotin antibodies-HRP or streptavidin-HRP, in combination with source
In the IgG or anti-rabbit of the species such as people, rat, mouse, rabbit and the secondary antibody of mouse, can not only indicate in electrophoresis process and after transferring film
The approximate location of albumen, and can on X film indicator protein position, increase pre-dyed marker swimming lane without additional.
Specific embodiment
For a clearer understanding of the technical characteristics, objects and effects of the present invention, detailed now in conjunction with following embodiments
Describe bright a specific embodiment of the invention in detail.
Embodiment one:
The preparation method for exposing pre-dyed albumen marker in the present embodiment includes the following steps:
S1, corresponding nucleic acid fragment sequence is designed according to protein band molecular size range each in pre-dyed luminescent protein marker
Column, and determine corresponding expression vector, the results are shown in Table 1;Wherein, the amino acid sequence of the protein band includes
One or several in SEQ ID NO.1~SEQ ID NO.6;The expression vector includes pET21a and/or pET28a-his-
MBP;
1 pre-dyed luminescent protein marker band of table composition
Container name | Albumen composition | Protein sequence | Molecular weight of albumen (kDa) |
pET21a | rFc1+mFc-1 | SEQ ID NO.1 | 35 |
pET21a | pA1+pG-1 | SEQ ID NO.2 | 43 |
pET21a | pA1+rFc1 | SEQ ID NO.3 | 60 |
pET21a | pA1+rFc1+mFc1 | SEQ ID NO.4 | 90 |
pET28a-his-MBP | pA2+rFc1 | SEQ ID NO.5 | 120 |
pET28a-his-MBP | MBP1+MBP2+pA3+rFc2 | SEQ ID NO.6 | 200 |
Note: pA:proteinA;pG:proteinG;RFc: rabbit source heavy chain constant region gene;MFc: small source of mouse antibody
Weight chain constant area gene;
S2, the preparation expression vector, and the nucleic acid fragment is obtained by PCR amplification;By nucleic acid fragment be connected to
Corresponding expression vector on, and be transferred in host cell and expressed, purified, to obtain different molecular weight corresponding with band
The luminescent protein of size;
Specifically, the step S2 includes:
S21, according in pMal-C2T (GenBank:JF795283.1) MBP nucleic acid sequence design his+MBP+ it is polyclonal
Sequence (sequence shown in SEQ ID NO.7) is synthesized by Sangon Biotech (Shanghai) Co., Ltd. and is built into described
PET28a-his-MBP carrier);
S22, synthesis staphylococcus aureus immunity Lysozyme binding protein A (proteinA) and streptococcus immune globulin
The complete genome sequence of white G binding protein G (proteinG);Purchase plasmid pFUSEss-CHIg-rG*03 (InvivoGen,
Catalog#pfusess-rchg) make with pFUSEss-CHIg-mG2b (InvivoGen, Catalog#pfusess-mchg2b)
For weight chain constant area gene (mFc) pcr template of rabbit source heavy chain constant region gene (rFc) and small source of mouse antibody;With from structure
The pET28a-his-MBP carrier built is MBP sequence pcr template;
S23, corresponding nucleic acid fragment is obtained with PCR amplification primer amplification shown in table 2, then passes through agarose gel electrophoresis
Separate and recover specific target fragment;Each target fragment is subjected to digestion and connection according to the protein combination in table 1;Recycling connection
It is transferred to host cell (including bacillus coli DH 5 alpha) after connecting after product with expression vector enzyme corresponding in table 1, obtains different molecular
Measure the expression plasmid of the luminescent protein of size;
2 design of primers table of table
S24, correct expression plasmid conversion e. coli bl21 (DE3) will be sequenced, and will carry out the inducing expression of albumen, specifically
Experimental implementation can refer to " molecular cloning handbook ";
And S25, the albumen by carrier for the plasmid expression of pET21a are purified with nickel ion affinity chromatograph;Carrier is
The albumen of the plasmid expression of pET28a-his-MBP maltose affinitive layer purification, the behaviour of specific various affinity chromatography column purifications
Make method and process is referred to the execution of protein purification laboratory manual, to obtain the hair of different molecular weight size corresponding with band
Photoprotein;
S3, the luminescent protein of different molecular weight size is mixed with dyestuff respectively, to obtain the pre-dyed egg of different molecular weight
It is white;
Specifically, the step S3 includes:
S31, the luminescent protein correspondence of different molecular weight size is placed in carbonate buffer solution, and the carbonate buffer
Liquid concentration is 0.1M, and it includes corresponding molecular size range luminescent protein to obtain several that pH, which is 9.5-10.5 (preferably 10.0),
Carbonate buffer liquid system;That is, the luminescent protein for being X1 comprising molecular weight in A kind carbonate buffer liquid system, B kind carbonate
The luminescent protein ... for being X2 comprising molecular weight in buffer solution system, and so on;
S32, dyestuff is dissolved in SDS (i.e. lauryl sodium sulfate) solution of mass fraction 10%, to obtain quality
Score is the dye solution of 1-2% (preferably 1.5%);
S33, by it is each include corresponding molecular size range luminescent protein carbonate buffer liquid system it is molten with dyestuff respectively
Liquid is mixed, and is incubated for 25-35min (preferably 30min) under the conditions of 55-65 DEG C (preferably 60 DEG C), to realize luminescent protein and dye
The covalent even chain of material;And count by volume, each carbonate buffer liquid system: dye solution=1:(0.5-1.5) (preferably 1:
1);In the present embodiment, the dyestuff includes Remazol (Lei Masu);
S34, the addition lysine equal with luminescent protein gross mass act under the conditions of 55-65 DEG C (preferably 60 DEG C)
10min crosses G25 column and removes extra dyestuff, adjustment luminescent protein concentration to about 0.15-0.25mg/ml (preferably 0.2mg/
Ml), to obtain the pre-dyed albumen of different molecular weight;
S4, the luminous intensity for detecting each albumen with Western-Bolt respectively, i.e., to the binding ability of antibody;According to single
Band luminous intensity adjustment by the pre-dyed albumen of different molecular weight size in preset weight ratio (in the present embodiment, different molecular
The weight for measuring the pre-dyed albumen of size is identical) mixing, then detected by Western-Bolt mixed as a result, and according to reality
Situation adjusts mixed proportion, to finally obtain the uniform mixture of band.By be incubated for different genera source different antibodies come
The stability for the marker band that shines is detected, to obtain to expose pre-dyed albumen marker.
The molecular weight for exposing pre-dyed albumen marker prepared in the present embodiment is 35-200kDa, by can
It proteinA, proteinG of binding antibody IgG and can be formed by the antibody Fc district amalgamation and expression of two anti-bindings, it then will fusion
Albumen and reactive dye Lei Masu (remazol) covalent coupling, to realize that same albumen is luminescent protein, and are pre-dyed eggs
White purpose, wherein it is not necessary that additional antibody, such as anti-biotin antibodies-HRP or streptavidin-HRP is added, in combination with next
Derived from the IgG or anti-rabbit of the species such as people, rat, mouse, rabbit and the secondary antibody of mouse, can not only refer in electrophoresis process and after transferring film
Show the approximate location of albumen, and can on X film indicator protein position, increase pre-dyed marker swimming lane without additional.
Embodiment two:
Present embodiments provide that a kind of preparation method according to embodiment one prepares exposes pre-dyed albumen
marker。
Embodiment three:
Pre-dyed albumen marker can be exposed by present embodiments providing described in a kind of embodiment two tests in Western-Blot
In application.
In conclusion preparation method of the invention is simple, easy to operate, it is not necessary that luminescent protein is prepared separately, prepare
Pre-dyed albumen marker can be exposed to be not necessarily to that additional antibody, such as anti-biotin antibodies-HRP or streptavidin-HRP is added,
In combination with from the IgG of species or the secondary antibody of anti-rabbit and mouse such as people, rat, mouse, rabbit, can not only in electrophoresis process and
The approximate location of indicator protein after transferring film, and can on X film indicator protein position, increase pre-dyed marker without additional
Swimming lane.
The foregoing is merely presently preferred embodiments of the present invention, is not intended to limit the invention, it is all in spirit of the invention and
Within principle, any modification, equivalent replacement, improvement and so on be should all be included in the protection scope of the present invention.
Claims (10)
1. the preparation method that one kind can expose pre-dyed albumen marker, which comprises the steps of:
S1, corresponding nucleic acid fragment is designed according to protein band molecular size range each in pre-dyed luminescent protein marker, and determine
Corresponding expression vector;
S2, the preparation expression vector, and the genetic fragment is obtained by PCR amplification;It is right therewith that nucleic acid fragment is connected to
It on the expression vector answered, and is transferred in host cell and expressed, purified, to obtain different molecular weight size corresponding with band
Luminescent protein;
S3, the luminescent protein of different molecular weight size is mixed with dyestuff respectively, to obtain the pre-dyed albumen of different molecular weight;
S4, the pre-dyed albumen of different molecular weight size is mixed by preset ratio, obtains that pre-dyed albumen marker can be exposed.
2. preparation method according to claim 1, which is characterized in that in the step S1, the amino of the protein band
Acid sequence includes one or several in SEQ ID NO.1~SEQ ID NO.6.
3. preparation method according to claim 1, which is characterized in that in the step S1, the expression vector includes
PET21a and/or pET28a-his-MBP.
4. preparation method according to claim 3, which is characterized in that the nucleic acid sequence of the pET28a-his-MBP carrier
Including sequence shown in SEQ ID NO.7.
5. preparation method according to claim 1, which is characterized in that the host cell includes E.coli.
6. preparation method according to claim 1, which is characterized in that the step S3 includes:
S31, the luminescent protein correspondence of different molecular weight size is placed in carbonate buffer solution, and the carbonate buffer solution is dense
Degree be 0.1M, pH 9.5-10.5, with obtain it is several include corresponding molecular size range luminescent protein carbonate buffer liquid
System;
S32, dyestuff is dissolved in the SDS solution of mass fraction 10%, to obtain mass fraction as the dye solution of 1-2%;
S33, by it is each include corresponding molecular size range luminescent protein carbonate buffer liquid system respectively with dye solution into
Row mixes, and is incubated for 25-35min under the conditions of 55-65 DEG C;And it counts by volume, each carbonate buffer liquid system: dye solution=
1:(0.5-1.5);
S34, the addition lysine equal with luminescent protein gross mass, act on 10min, it is extra to remove under the conditions of 55-65 DEG C
Dyestuff adjusts luminescent protein concentration to about 0.15-0.25mg/ml, to obtain the pre-dyed albumen of different molecular weight.
7. preparation method according to claim 1, which is characterized in that the dyestuff includes Remazol.
8. preparation method according to claim 1, which is characterized in that the molecular weight for exposing pre-dyed albumen marker
For 35-200kDa.
9. what a kind of any one of -8 preparation methods according to claim 1 prepared exposes pre-dyed albumen marker.
10. application of the pre-dyed albumen marker in Western-Blot experiment can be exposed described in a kind of claim 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910709005.4A CN110408639A (en) | 2019-08-01 | 2019-08-01 | Pre-dyed albumen marker and preparation method thereof, application can be exposed |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910709005.4A CN110408639A (en) | 2019-08-01 | 2019-08-01 | Pre-dyed albumen marker and preparation method thereof, application can be exposed |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110408639A true CN110408639A (en) | 2019-11-05 |
Family
ID=68365167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910709005.4A Pending CN110408639A (en) | 2019-08-01 | 2019-08-01 | Pre-dyed albumen marker and preparation method thereof, application can be exposed |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110408639A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2874473Y (en) * | 2005-11-11 | 2007-02-28 | 侯志波 | Predyeing multicolor protein molecular weight standard reagent box |
WO2011068340A2 (en) * | 2009-12-01 | 2011-06-09 | 주식회사 인트론바이오테크놀로지 | Synthetic nonionic hydrophilic polymer-based prestained protein size marker |
CN104818290A (en) * | 2015-01-28 | 2015-08-05 | 华侨大学 | Protein molecular weight standard preparation method |
CN104862332A (en) * | 2015-06-05 | 2015-08-26 | 武汉华美生物工程有限公司 | Preparation method of protein exposure marker |
CN107298719A (en) * | 2017-08-17 | 2017-10-27 | 天德悦(北京)生物科技有限责任公司 | Pre-dyed luminescent protein marker preparation method |
CN107383208A (en) * | 2017-08-17 | 2017-11-24 | 天德悦(北京)生物科技有限责任公司 | Luminescent protein marker preparation method |
-
2019
- 2019-08-01 CN CN201910709005.4A patent/CN110408639A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2874473Y (en) * | 2005-11-11 | 2007-02-28 | 侯志波 | Predyeing multicolor protein molecular weight standard reagent box |
WO2011068340A2 (en) * | 2009-12-01 | 2011-06-09 | 주식회사 인트론바이오테크놀로지 | Synthetic nonionic hydrophilic polymer-based prestained protein size marker |
CN104818290A (en) * | 2015-01-28 | 2015-08-05 | 华侨大学 | Protein molecular weight standard preparation method |
CN104862332A (en) * | 2015-06-05 | 2015-08-26 | 武汉华美生物工程有限公司 | Preparation method of protein exposure marker |
CN107298719A (en) * | 2017-08-17 | 2017-10-27 | 天德悦(北京)生物科技有限责任公司 | Pre-dyed luminescent protein marker preparation method |
CN107383208A (en) * | 2017-08-17 | 2017-11-24 | 天德悦(北京)生物科技有限责任公司 | Luminescent protein marker preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lopata et al. | In vivo microtubules are copolymers of available beta-tubulin isotypes: localization of each of six vertebrate beta-tubulin isotypes using polyclonal antibodies elicited by synthetic peptide antigens. | |
Whalen et al. | Contractile protein isozymes in muscle development: identification of an embryonic form of myosin heavy chain. | |
Bertrand et al. | Crosslinking of the skeletal myosin subfragment-1 heavy chain to the N-terminal actin segment of residues 40-113 | |
Majumder et al. | Involvement of tyrosyl-tRNA synthetase in splicing of group I introns in Neurospora crassa mitochondria: biochemical and immunochemical analyses of splicing activity | |
CN109053883B (en) | Binding protein of NS1 protein | |
CN109053882B (en) | A kind of binding protein of NS1 albumen and application | |
CN111624349A (en) | Novel coronavirus 2019-nCoV antibody spectrum detection test strip | |
CN107383208A (en) | Luminescent protein marker preparation method | |
CN103728447A (en) | Controllable quantum dot locus specificity bridging coupling antibody marking method and application | |
BR112014025693B1 (en) | METHOD OF RECOMBINANT PRODUCTION OF A POLYPEPTIDE IN A BACTERIAL CELL | |
CN111665365A (en) | Novel coronavirus 2019-nCoV antibody spectrum detection kit | |
JP3536731B2 (en) | HIV-1 p24 antigen immunoassay method and reagent | |
KR20210056362A (en) | NS1-binding protein | |
CN108484779A (en) | A kind of fusion protein and the application of nano antibody and human placental alkaline phosphatase | |
CN110408639A (en) | Pre-dyed albumen marker and preparation method thereof, application can be exposed | |
KR20210049893A (en) | NS1-binding protein | |
CN107298719A (en) | Pre-dyed luminescent protein marker preparation method | |
Li et al. | Selective separation procedure for determination of ribosomal proteins L7 and L12 | |
CN109374886B (en) | Infectious bovine rhinotracheitis virus antibody detection kit and application thereof | |
CN110894243A (en) | Porcine reproductive and respiratory syndrome virus chimeric antigen and colloidal gold immunochromatographic test strip for detecting porcine reproductive and respiratory syndrome virus antibody | |
Bullock et al. | Immunochemical assays of serum proteins: a European external quality assessment survey and the effects of calibration procedures on interlaboratory agreement | |
Maruyama et al. | Hemoglobins of the tadpole of the bullfrog, Rana catesbeiana. Amino acid sequence of the alpha chain of a major component. | |
CN104862332A (en) | Preparation method of protein exposure marker | |
Alloza et al. | Cross-linking approach to affinity capture of protein complexes from chaotrope-solubilized cell lysates | |
CN111548412B (en) | Hepatitis B surface antigen monoclonal antibody, preparation method, application and amino acid sequence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191105 |
|
RJ01 | Rejection of invention patent application after publication |